Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Insights into the gut microbiome of vitiligo patients from India

In an Indian cohort, vitiligo patients showed gut dysbiosis with a lower Firmicutes to Bacteroidetes ratio, depletion of butyrate-producing bacteria, and more mucin-degrading genes, and a cross-cohort classifier separated patients from controls with about 82 percent accuracy.

2026-07-05

Breast cancer in postmenopausal women is associated with an altered gut metagenome

The gut microbiota of postmenopausal breast cancer patients showed higher microbial diversity and 45 differentially abundant species (38 enriched, including Escherichia coli, Klebsiella, Prevotella amnii, and Enterococcus gallinarum) compared with matched controls, whereas premenopausal patients showed no significant compositional differences.

2026-07-05

Gut Microbiota Composition Changes in Constipated Women of Reproductive Age

In 29 constipated women of reproductive age versus 30 healthy controls, gut microbiota composition shifted even though overall diversity was similar. Constipated women had more Bacteroidetes and less Proteobacteria, a lower Firmicutes-to-Bacteroidetes ratio of 1.52 versus 2.21, and fewer butyrate-producing bacteria.